Genocea Biosciences
GNCA
$0.0001000
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Genocea Biosciences (GNCA) - Total assets
Total assets on the balance sheet as of March 2022 : $38.78 M
According to Genocea Biosciences 's latest financial reports the company's total assets are $38.78 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Genocea Biosciences - Total assets on balance sheet (from 2012 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2021-12-31 | $55.96 M | -43.18% |
| 2020-12-31 | $98.49 M | 87.21% |
| 2019-12-31 | $52.61 M | 69.09% |
| 2018-12-31 | $31.11 M | 77.92% |
| 2017-12-31 | $17.48 M | -74.98% |
| 2016-12-31 | $69.89 M | -37.67% |
| 2015-12-31 | $0.11 B | 122.37% |
| 2014-12-31 | $50.43 M | 219.97% |
| 2013-12-31 | $15.76 M | 16.48% |
| 2012-12-31 | $13.53 M | 94.97% |
| 2011-12-31 | $6.94 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 583,846.07% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 274,920.62% | 🇺🇸 USA |
 Novavax NVAX | $1.79 B | 4,534.14% | 🇺🇸 USA |
 Agenus
AGEN | $0.31 B | 709.30% | 🇺🇸 USA |
 iBio IBIO | $34.02 M | -12.29% | 🇺🇸 USA |